[Special Stock] SK Bioscience Surges to New 52-Week High
[Asia Economy Reporter Park So-yeon] SK Bioscience surged and hit a 52-week high.
As of 9:54 a.m. on the 17th, SK Bioscience was trading at 310,500 KRW on the Korea Exchange, up 7.63% (22,000 KRW) from the previous trading day. During the session, it soared to 327,000 KRW, setting a new 52-week high.
Hot Picks Today
!["Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026051507261063923_1778797570.png)
"Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- While All Eyes Were on Samsung and Hynix, This Company Surged 50% to New Highs in Four Days [Weekend Money]
- "Now Our Salaries Are 10 Million Won a Month" Record High... Semiconductor Boom Drives Performance Bonuses at Major Electronic Component Firms
- "150 Trillion-Won National Growth Fund Launches... Construction Stocks Stir Again" [Weekend Money]
- Experts Already Watching Closely..."Target Price Set at 970,000 Won" Only Upward Momentum Remains [Weekend Money]
SK Bioscience surpassed 300,000 KRW on the 10th following the news of approval for Phase 3 clinical trials of its COVID-19 vaccine. At that time, the Ministry of Food and Drug Safety announced that it had approved the Phase 3 clinical trial plan for 'GBP510,' a COVID-19 vaccine candidate developed by SK Bioscience. The company aims for commercialization in the first half of next year, and if successful, hundreds of millions of doses of the domestically produced vaccine are expected to be supplied worldwide.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
